Xtant Medical Holdings Inc.Find Ratings Reports
XTANT MEDICAL HOLDINGS INC's gross profit margin for the first quarter of its fiscal year 2020 is essentially unchanged when compared to the same period a year ago. Even though sales decreased, the net income has increased. XTANT MEDICAL HOLDINGS INC has average liquidity. Currently, the Quick Ratio is 1.29 which shows that technically this company has the ability to cover short-term cash needs. The company's liquidity has decreased from the same period last year, indicating deteriorating cash flow.
During the same period, stockholders' equity ("net worth") has decreased by 18.63% from the same quarter last year. Together, the key liquidity measurements indicate that it is relatively unlikely that the company will face financial difficulties in the near future.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
|Income Statement||Q1 FY20||Q1 FY19|
|Net Sales ($mil)||14.78||16.73|
|Net Income ($mil)||-2.49||-2.8|
|Balance Sheet||Q1 FY20||Q1 FY19|
|Cash & Equiv. ($mil)||3.24||7.1|
|Total Assets ($mil)||42.55||47.07|
|Total Debt ($mil)||79.51||75.75|
|Profitability||Q1 FY20||Q1 FY19|
|Gross Profit Margin||69.68||69.29|
|Return on Assets||-18.6||-143.72|
|Return on Equity||0.0||0.0|
|Debt||Q1 FY20||Q1 FY19|
|Share Data||Q1 FY20||Q1 FY19|
|Shares outstanding (mil)||13.22||13.16|
|Div / share||0.0||0.0|
|Book value / share||-3.51||-2.98|
|Institutional Own %||n/a||n/a|
|Avg Daily Volume||678191.0||7121.0|
SELL. The current P/E ratio is negative, which has no meaningful value in the assessment of premium or discount valuation, it simply displays that the company has negative earnings. Along with this, the price-to-book ratio is also meaningless due to a negative book value for the company, making any comparisons useless. The price-to-sales ratio is well below both the S&P 500 average and the subsector average, indicating a discount.
|XTNT NM||Peers 80.73||XTNT NM||Peers 56.95|
Neutral. The absence of a valid P/E ratio happens when a stock can not be valued on the basis of a negative stream of earnings.
XTNT's P/E is negative making this valuation measure meaningless.
Neutral. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.
XTNT's P/CF is negative making the measure meaningless.
|XTNT NA||Peers 62.70||XTNT NA||Peers 14.76|
Neutral. A lower price-to-projected earnings ratio than its peers can signify a less expensive stock or lower future growth potential.
Ratio not available.
Neutral. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.
Ratio not available.
|XTNT NM||Peers 14.48||XTNT 88.14||Peers 64.38|
Neutral. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.
XTNT's P/B is negative making this valuation measure meaningless.
Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.
XTNT is expected to have an earnings growth rate that significantly exceeds its peers.
|XTNT 0.21||Peers 8.23||XTNT -11.64||Peers 12.90|
Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.
XTNT is trading at a significant discount to its subsector on this measurement.
Lower. A sales growth rate that trails the subsector implies that a company is losing market share.
XTNT significantly trails its peers on the basis of sales growth.